310 related articles for article (PubMed ID: 21129041)
1. Dead Sea climatotherapy for vitiligo: a retrospective study of 436 patients.
Czarnowicki T; Harari M; Ruzicka T; Ingber A
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):959-63. PubMed ID: 21129041
[TBL] [Abstract][Full Text] [Related]
2. Climatotherapy at the Dead Sea: an effective treatment modality for atopic dermatitis with significant positive impact on quality of life.
Adler-Cohen C; Czarnowicki T; Dreiher J; Ruzicka T; Ingber A; Harari M
Dermatitis; 2012; 23(2):75-80. PubMed ID: 22653123
[TBL] [Abstract][Full Text] [Related]
3. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS).
Schallreuter KU; Moore J; Behrens-Williams S; Panske A; Harari M
Int J Dermatol; 2002 Aug; 41(8):482-7. PubMed ID: 12207762
[TBL] [Abstract][Full Text] [Related]
4. Outcome of "short-term" Dead Sea climatotherapy for psoriasis.
Cohen AD; Shapiro J; Michael D; Hodak E; Van-Dijk D; Naggan L; Vardy DA
Acta Derm Venereol; 2008; 88(1):90-1. PubMed ID: 18176769
[No Abstract] [Full Text] [Related]
5. The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea.
Harari M; Novack L; Barth J; David M; Friger M; Moses SW
Int J Dermatol; 2007 Oct; 46(10):1087-91. PubMed ID: 17910722
[TBL] [Abstract][Full Text] [Related]
6. Actinic damage among patients with psoriasis treated by climatotherapy at the Dead Sea.
David M; Tsukrov B; Adler B; Hershko K; Pavlotski F; Rozenman D; Hodak E; Paltiel O
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):445-50. PubMed ID: 15761422
[TBL] [Abstract][Full Text] [Related]
7. Dead Sea ultraviolet climatotherapy for children with atopic dermatitis.
Kudish A; Marsakova A; Jahn I; Gkalpakiotis S; Arenberger P; Harari M
Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):254-261. PubMed ID: 27379840
[TBL] [Abstract][Full Text] [Related]
8. Effect of the Dead Sea climatotherapy for psoriasis on quality of life.
Kopel E; Levi A; Harari M; Ruzicka T; Ingber A
Isr Med Assoc J; 2013 Feb; 15(2):99-102. PubMed ID: 23516771
[TBL] [Abstract][Full Text] [Related]
9. An open trial of climatotherapy at the Dead Sea for patch-stage mycosis fungoides.
Hodak E; Gottlieb AB; Segal T; Maron L; Lotem M; Feinmesser M; David M
J Am Acad Dermatol; 2004 Jul; 51(1):33-8. PubMed ID: 15243521
[TBL] [Abstract][Full Text] [Related]
10. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
[TBL] [Abstract][Full Text] [Related]
11. Significant immediate and long-term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the Dead Sea.
Krüger C; Smythe JW; Spencer JD; Hasse S; Panske A; Chiuchiarelli G; Schallreuter KU
Acta Derm Venereol; 2011 Mar; 91(2):152-9. PubMed ID: 21240455
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
[TBL] [Abstract][Full Text] [Related]
13. Patients with early-onset psoriasis achieve better results following Dead Sea climatotherapy.
Harari M; Czarnowicki T; Fluss R; Ruzicka T; Ingber A
J Eur Acad Dermatol Venereol; 2012 May; 26(5):554-9. PubMed ID: 21575063
[TBL] [Abstract][Full Text] [Related]
14. Climatotherapy at the dead sea for pediatric-onset psoriasis vulgaris.
Ben-Amitai D; David M
Pediatr Dermatol; 2009; 26(1):103-4. PubMed ID: 19250425
[TBL] [Abstract][Full Text] [Related]
15. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
Saraceno R; Nisticò SP; Capriotti E; Chimenti S
Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
[TBL] [Abstract][Full Text] [Related]
16. Long-term results in the treatment of vitiligo with oral khellin plus UVA.
Hofer A; Kerl H; Wolf P
Eur J Dermatol; 2001; 11(3):225-9. PubMed ID: 11358729
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
[TBL] [Abstract][Full Text] [Related]
19. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
Lahiri K; Malakar S; Sarma N; Banerjee U
Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
[TBL] [Abstract][Full Text] [Related]
20. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
